A subscription to JoVE is required to view this content. Sign in or start your free trial.
This current protocol outlines a procedure for creating a rat model of osteosarcopenia using ovariectomy.
Osteosarcopenia (OS), a complex degenerative disorder, is characterized by the concurrent decline in skeletal muscle mass and bone mineral density (BMD), posing an enormous health hazard for the elderly population. Despite its clinical relevance, the pathophysiological mechanisms underlying OS are not fully understood, underscoring the necessity for a deeper comprehension of its etiology to facilitate effective treatment strategies. The development of a reliable animal model is pivotal in this endeavor. This study presents a refined protocol for the induction of postmenopausal osteosarcopenia in rats through bilateral ovariectomy, a method known to accelerate the onset of age-related muscle and bone loss. In this study, rats aged 12 weeks were stratified by body weight and randomly assigned to either a sham operation group or an ovariectomized (OVX) group. Tissue samples from the quadriceps and triceps muscles of the left hind limb, as well as the left femur, were systematically collected at 4, 8, and 12 weeks post-surgery. This methodical approach ensures a comprehensive evaluation of the effects of ovariectomy on muscle and bone health. Histological evaluation of muscle fiber atrophy and femoral morphology was conducted using hematoxylin and eosin (HE) staining, while bone mineral density was quantified using dual-energy X-ray absorptiometry (DXA). The temporal progression of OS was meticulously monitored at the aforementioned intervals, providing insights into the dynamic interplay between muscle and bone degeneration. This model not only accurately reflects the clinical manifestations of OS but also serves as a robust platform for investigating novel therapeutic approaches and their underlying mechanisms.
Osteosarcopenia is a multifaceted degenerative condition that encapsulates the clinical manifestations of both osteoporosis and sarcopenia1,2,3,4. Osteoporosis, a prevalent skeletal disorder, is characterized by diminished bone mass, compromised microarchitecture, and heightened susceptibility to fractures. Sarcopenia, often referred to as muscle wasting syndrome, is typified by a reduction in muscle strength and mass5,6. Maryam's7 findings revealed that o....
Female Sprague Dawley rats (n = 36), aged 12 weeks and weighing approximately 200-240 g, were housed individually in ventilated cages in a specific-pathogen-free (SPF) animal room with a 12-h light/dark cycle. They had free access to SPF feed and sterile water. The rats were allowed to acclimate to the environment for a week before the experiments. Using random allocation, the rats were divided into ovariectomized (OVX) groups (each with 6 rats) and sham groups (each with 6 rats) for 4, 8, and 12 weeks post-surgery. All animal procedures were carried out following the approved guidelines of the animal welfare committee at Liaoning University of Traditional Chinese Med....
This protocol provides a detailed description of the bilateral ovariectomy procedure for establishing a rat model of Osteosarcopenia. Figure 3 demonstrates a decrease in the wet weight coefficient of the quadriceps muscle in the OVX group in comparison to the sham group. Although there was no statistically significant variance in BMD between the two groups 4 weeks after surgery, the BMD in the OVX group was significantly lower than that in the sham-operated g.......
The bilateral ovariectomized animal model is instrumental in elucidating the mechanisms underlying osteosarcopenia and assessing potential therapeutic interventions. Ovariectomy-induced osteoporosis in rats, which mirrors the abrupt decrease in estrogen levels seen in postmenopausal women, is commonly employed as a model for osteoporosis research. Furthermore, research has highlighted a significant association between osteoporosis and sarcopenia in older individuals, with concurrent muscle and bone loss frequently observ.......
Each author declares no competing financial interests.
This work is supported by grants from (1) National Nature Science Foundation (82305275). (2) Liaoning Provincial Natural Science Foundation program (2022-YGJC-80 and 2022-YGJC-79). (3) High-level Chinese Medicine Key Discipline Construction Project of National Administration of TCM (zyyzdxk-2023040).
....Name | Company | Catalog Number | Comments |
Double lion Irradiated Rodent Diet | Suzhou Shuangshi Experimental Animal Feed Technology Co., Ltd. | GB 14924.3 | Animal feed |
Disposable medication changing tray | Yangzhou Chenglin Medical Technology Co., Ltd. | RVnpFXLc | |
Dual Energy X-ray Bone Densitometer | Xuzhou PinyuanElectronic Technology Co., Ltd. | DXA-800E | |
Iodine | Shanghai Likang Sterilization Hi-Tech Co., Ltd. | LK-310512 | |
IVCs rat cage | Suzhou Monkey King Animal Experimental Equipment Technology Co., Ltd. | HH-MMB-2 | Animal barrier |
Penicillin sodium | North China Pharmaceutical Group Limited Liability Co., Ltd. | H13020654 | |
sodium pentobarbital | Sigma-Aldrich, St. Louis, MO | P3761-5G | |
Sterile cotton ball | Henan Piaoan Group Co., Ltd | 20140017 | |
Straight Mayo scissors | Shenzhen Huayang Biotechnology Co., Ltd. | 18-0410 | |
Straight needle holder | Shanghai Simplicity Biotechnology Co., Ltd. | 32100-14 | |
Suture line | Shenzhen Huayang Biotechnology Co., Ltd. | 18-5902 | |
Suture needle | Shenzhen Huayang Biotechnology Co., Ltd. | 18-5036 | |
Syringes | Shenzhen Huayang Biotechnology Co., Ltd. | 21-3021 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionExplore More Articles
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved